Full Text View
Tabular View
No Study Results Posted
Related Studies
The Qutenza Patch as Treatment for Disabling Treprostinil (Remodulin) Infusion Site Pain
The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2010 by University of Rochester.
Recruitment status was  Recruiting
Study NCT01260454   Information provided by University of Rochester

First Received on December 9, 2010.   Last Updated on December 13, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Pulmonary Hypertension
Pulmonary Arterial Hypertension
Additional conditions recognized in this trial
Hypertension
Hypertension, Pulmonary
More general conditions related to this trial
Cardiovascular Diseases
Lung Diseases
Respiratory Tract Diseases
Vascular Diseases
Interventions listed in this trial
Qutenza (8% capsaicin)
Additional drug interventions recognized in this trial
Capsaicin
Treprostinil
More general drug interventions related to this trial
Antihypertensive Agents
Antipruritics
Cardiovascular Agents
Dermatologic Agents
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
University of Rochester
United Therapeutics


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services